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Abstract 
Two-dimensional elemental mapping (bioimaging) via laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) was 
performed on 5 µm thick formalin-fixed, paraffin-embedded kidney tissue sections from Cynomolgus monkeys administered with increasing 
pharmacological doses of cisplatin. Laterally resolved pixels of 1 µm were achieved, enabling elemental analysis on a (sub-)cellular level. 
Zones of high Pt response were observed in the renal cortex, where proximal tubules are present, the epithelium of which is responsible for 
partial reabsorption of cisplatin. Histopathological evaluation, of hematoxylin and eosin-stained serial sections, adjacent to the sections 
probed via LA-ICP-MS, revealed minimal to mild cisplatin-related lesions (< 100 µm) in the renal cortex. Necrotic proximal tubules with 
sloughed epithelial cells in their lumen could be linked directly to the areas with the highest accumulation of cisplatin, indicating a direct 
link between cellular concentration and toxicity, thereby providing more insight into the mechanisms through which renal damage occurs. 
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1. Introduction 
Cisplatin (cis-diamminedichloroplatinum [II], CDDP) was the first platinum-containing chemotherapeutic agent and is now approved 
for the treatment of solid tumors, e.g., testicular, cervical, colorectal, lung, ovarian, head and neck cancer [1–3]. Unfortunately, a major 
drawback of cisplatin use is the occurrence of severe and dose-limiting side effects, e.g., vomiting, ototoxicity, neurotoxicity and 
nephrotoxicity [4]. Drug-induced kidney injury (DIKI) is an adverse event, in which excretion is disrupted due to exposure to toxic 
compounds [5]. No regulatory authority guidance regulates stand-alone kidney safety pharmacology studies. Therefore, exploratory 
repeat-dose DIKI studies are not routinely conducted by pharmaceutical companies, particularly not in non-human primates [6]. While 
the incidence of translatable DIKI is low, DIKI remains a significant cause of candidate drug attrition during the clinical d rug 
development phase and post-marketing period [7]. Recently, DIKI has been reported to contribute to approximately 25% of the cases of 
hospital-acquired acute kidney injury (AKI) events [8]. Despite restricted patient doses [9], approximately one in three patients suffers 
from nephrotoxicity after cisplatin chemotherapy, which endangers the kidneys’ vital functions in the genitourinary and cardiovascular 
systems [3,4]. 
The renal system excretes metabolic waste products by filtering the blood and it is responsible for maintaining water, electrolyte and 
acid-base balances in the body. Moreover, the kidneys regulate the production of vitamin D, by synthesizing calcitriol, and the secretion 
of the hormone erythropoietin, which stimulates red blood cell production in the bone marrow [10]. Renal cortical and medullary tissue 
consists of vascular and tubular elements in close proximity to each other, with the interstitium, i.e. interstitial fluid and interstitial cells, 
in-between them [10]. In humans, a normal kidney consists of approximately 1 million of nephrons, which start in the cortex and end in 
the papilla [11]. Figure 1 provides a schematic representation of a short-looped and long-looped nephron. Each nephron is subdivided in 
multiple tubular segments, which differ functionally and structurally from one another, starting with the renal corpuscle, i.e. Bowman’s 
capsule surrounding the glomerulus, a tuft of capillary loops through which the blood flows [11]. In this structure, blood filtration occurs 
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whereby water, electrolytes and small proteins are removed from the capillaries and enter the Bowman’s capsule [11]. This filtrate flows 
further into the proximal convoluted tubule (PCT) and proximal straight tubule, where large amounts of water, electrolytes, glucose and 
amino acids are reabsorbed from the filtrate [10]. Furthermore, secretion of some administered drugs takes place in this region of the 
nephron [10]. The next tubular segments are the loop of Henle, distal convoluted tubule (DCT), connecting tubule, cortical and medullary 
collecting ducts, which are all responsible for numerous reabsorption processes and the delivery of the final urine to the minor calyx 
[10]. 
 
Figure 1. Schematic representation of the nephrons, the functional units of the kidney. The regions of the cortex, outer and inner stripe of the outer 
medulla and the inner medulla are separated by the dashed lines. The numbers are indicating different tubular segments: (1) renal corpuscle, (2) proximal 
convoluted tubule, (3) proximal straight tubule, (4) thin descending limb, (5) thin ascending limb, (6) thick ascending limb, (7) macula densa, (8) distal 
convoluted tubule, (9) connecting tubule and (10) collecting duct. The nomenclature is based on standard nomenclature for structures of the kidney [12]. 
In the case of nephrotoxicity, cisplatin accumulation can occur locally in renal tissue [13], where cisplatin is taken up in cortical tubular 
epithelial cells of proximal and distal tubules via passive diffusion and via copper transporters, P-type copper-transporting ATPases, 
multi-drug extrusion transporters and organic cation transporters (OCTs) [3,4,14,15]. In renal tissue, especially OCT2 plays a major role 
in cisplatin nephrotoxicity as being a kidney-specific transporter protein, it is omnipresent in proximal tubular epithelium at the 
basolateral membrane [3]. The identification of the molecular mechanisms involved is ongoing. Once cisplatin enters cells, it binds to 
nucleophilic molecules, e.g., proteins, RNA and DNA, which may trigger DNA cross-linking, apoptosis and necrosis [1,4]. Subsequently, 
this phenomenon may lead to severe renal tissue damage, decreased glomerular filtration rate and ultimately, renal failure [4]. Because 
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the mechanisms responsible for nephron segment-specific DIKI remain poorly understood, there is a great need for sensitive, label-free 
methods for visualizing and quantifying the distribution of candidate drugs in the kidney to support investigational studies of 
nephrotoxicity during drug research and development. 
Laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) is a well-known analytical technique capable of performing 
quantitative spatially resolved analysis of elemental distributions with µm lateral resolution. The main features of LA-ICP-MS include 
minimal sample preparation, wide linear dynamic range, multi-element capability and low limits of detection. Bioimaging via LA-ICP-
MS was first proposed by Wang et al. [16] and has gradually gained interest in the bioanalytical field and has been utilized to visualize 
the distribution of endogenous metals in numerous tissues, e.g., mouse brain, heart and spinal cord tissue [17–20], human brain, lung, 
lymph node tissue and kidney stones [21–24] and metal-labelled antibodies designed to target specific antigens [25–31]. Analysis of the 
distribution of administered pharmaceutical agents such as cisplatin in target and non-target tissues has been performed in many studies 
[32–42], providing profound insights into depth of tissue penetration, metabolic fate in vivo, and serious adverse effects which, in turn, 
can enhance the success rate of utilizing cisplatin as a prototype to develop LA-ICP-MS methods that may be adapted to further evaluate 
candidate drugs or their metabolites with known kidney safety liabilities, particularly during the early stages of the drug development 
process [32]. 
Accurate quantification protocols in LA-ICP-MS require matrix-matched standards, online solution addition calibration, or isotope 
dilution [43–45]. A recent review by Limbeck et al. [46] summarized calibration strategies and approaches for the preparation of 
standards, including sections of spiked tissue homogenates [21], spiked  blood [47], spiked polymethylmethacrylate spin-coated on quartz 
slides [48], printed standards [49–52], and dried droplet standards [53]. Based on their density and water content, spiked gelatin standards 
are pseudo-matrix-matched to biological tissues and can be applied as an inexpensive and simple alternative [34,54–56]. In this work, 
spiked gelatin droplet standards, with In as an internal standard, were prepared for quantification purposes. A low dispersion mixing 
bulb, ARIS [57], which was developed at Ghent University and is commercialized by Teledyne CETAC Technologies, was also used to 
provide rapid aerosol washout, higher sensitivity and higher spatial resolution. 
This study illustrates the capabilities of LA-ICP-MS to perform high-resolution mapping of the distribution of this metal-containing drug 
on a cellular level, by localizing cisplatin in representative formalin-fixed, paraffin-embedded kidneys from Cynomolgus monkeys with 
cisplatin-induced cortical proximal tubular lesions. To the best of the authors’ knowledge, this is the first time renal cisplatin distribution 
patterns have been revealed on a (sub-)cellular level in combination with histopathological findings in Cynomolgus monkey kidneys via 
high-resolution LA-ICP-MS imaging. 
2. Experimental section 
2.1. Samples and standards 
The kidney tissues originated from a 4-day cisplatin nephrotoxicity study in male and female Cynomolgus monkeys (Macaca 
fascicularis). The testing facility was located at WuXi AppTec Co., Ltd. (Suzhou, China) and all steps in this research were performed 
in compliance with the regulations and guidelines concerning animal care and welfare, according to the AAALAC International 
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guidelines, as stated in the Guide for the Care and Use of Laboratory Animals (National Research Council, 2011) and the Regulations 
for the Administration of Affairs Concerning Experimental Animals (People’s Republic of China, Ministry of Science & Technology, 
1988). Twenty-four animals, including twelve males and twelve females, were randomly divided into 4 groups and were intravenously 
administered with a single infusion of vehicle (0.9% NaCl) or cisplatin (0.625, 1.25 and 2.50 µg g-1 body weight (bw)) in the same 
vehicle. The high dose (2.50 µg g-1 bw) was selected to induce minimal-to-marked kidney lesions, whereas the mid dose (1.25 µg g-1 
bw) could lead to minimal kidney damage. The low dose (0.625 µg g-1 bw) was assumed to induce minimal systemic toxicity. Yellow-
to-orange cisplatin powder (100% purity) (Fitzgerald Industries International, Acton, MA, USA) was used to prepare the infuse solutions, 
by dissolving specific amounts of powder in vehicle solution. The animals were housed in a controlled environment under a 12-hour 
light/dark cycle with free access to water and were fed twice a day. Four days after administration, the animals were anesthetized and 
euthanized, followed by tissue collection. Kidney tissues intended for LA-ICP-MS analysis were formalin-fixed in 10% neutral buffered 
formalin and paraffin-embedded (FFPE). The FFPE kidney sections were sectioned into 5 µm thin sections, which were placed on 
Superfrost glass microscopic slides (Thermo Fisher Scientific, Waltham, MA, USA).  
The preparation procedure for the gelatin standard solutions (10% w/v) started with the addition of 100 mg of gelatin powder (VWR 
International, Leuven, Belgium) into a 1.5 mL microcentrifuge tube [34]. Different volumes of 1,000 µg mL-1 Pt and In stock solutions 
(Inorganic Ventures, USA) were added to the gelatin powder. Milli-Q water from a purification system, Direct-Q3 (Millipore, Molsheim, 
France) was added as to obtain a 0 (blank), 10, 20 or 50 µg g-1 Pt standard with 50 µg g-1 In. The microcentrifuge tubes were placed in a 
laboratory water bath at 65 °C to melt the gelatin and proper mixing was achieved by placing the tubes for 2 minutes onto a vortex system 
(VWR International, Leuven, Belgium). Four gelatin standard solutions were spotted with a micropipette onto a microscope cover glass 
and the tiny droplets of 200 - 400 µg were weighed using a M3P microbalance (Sartorius, Göttingen, Germany).  
2.2. Instrumentation 
An Analyte G2 193 nm ArF* excimer-based laser ablation (LA) system (Teledyne CETAC Technologies, Omaha, NE, USA) was 
coupled to a quadrupole-based XSeries-II ICP-MS instrument (Thermo Fisher Scientific, Santa Clara, CA, USA) to map the Pt 
distribution in Cynomolgus monkey FFPE kidney sections with laterally resolved pixels down to 3 µm. The LA system was equipped 
with a HelEx II 2-volume ablation cell. Helium was used as a carrier gas for aerosol transport from the sample surface to the ICP and 
was mixed with Ar as a make-up gas in an ARIS mixing bulb before entering the plasma. Operational parameters of the ICP-MS and 
laser were tuned for maximum sensitivity, low oxide formation (< 1%) based on the 238U16O+/238U+ ratio and low laser-induced elemental 
fractionation based on the 238U+/232Th+ ratio (≈ 1) using NIST SRM 612 glass certified reference material (National Institute for Standards 
and Technology, Gaithersburg, MD, USA). In order to evaluate the macroscopic cisplatin distribution in regions of the renal cortex and 
medulla, an overview scan of a radial segment crossing through these regions was desired; a radial segment was rastered using adjacent 
scans with a circular laser spot of 15 µm diameter, 4.72 J cm-2 output energy, 120 µm s-1 scan speed, 50 Hz repetition rate. The optimal 
conditions were achieved at a radiofrequency (RF) power of 1350 W and cooling gas (Ar), auxiliary gas (Ar) and make-up gas (Ar) flow 
rates of 13, 0.70 and 0.68 L min-1, respectively. The carrier gas (He) flow rates were optimized to 0.49 - 0.55 L min-1. 195Pt and 115In 
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were monitored with dwell times of 25 and 7 ms, respectively. Small cortical regions of interest (ROI), selected based on features in the 
hematoxylin and eosin (H&E)-stained sequential section were analysed with higher spatial resolution. The laser parameters were adjusted 
to a circular spot size with a diameter of 3 µm, 3.04 J cm-2 output energy, 20 µm s-1 scan speed and 60 Hz repetition rate. The size of the 
rastered zone was adjusted to match the ROI. The laser ablation system was also coupled to a quadrupole-based Agilent 7900 ICP-MS 
(Agilent Technologies, Waltham, MA, USA) to enable laterally resolved pixels of 1 µm in the ROI images.† 
2.3. Calibration 
External calibration, based on spiked gelatin droplet standards, was applied for the quantification of cisplatin in selected radial segment 
scans. Spotted, spiked droplets were ablated in their entirety prior to mapping, whilst applying identical instrument settings and data 
acquisition parameters. Signal responses for each mass channel monitored during ablation of a single spiked droplet were integrated after 
background subtraction. The integrated signal of In, which was incorporated in the gelatin as an internal standard, was used to correct 
for sensitivity drift throughout the measurement runs. The 195Pt integrated response 𝑅𝑃𝑡,𝑖 for each droplet 𝑖 was normalized using the 
115In integrated response 𝑅𝐼𝑛,𝑖 of the droplet 𝑖, its mass 𝑚𝑖, and the temporally-averaged 
115In integrated response 𝑅𝐼𝑛̅̅ ̅̅̅ of all 𝑛 droplets 
and the average mass of all 𝑛 droplets ?̅?. The normalized 195Pt response 𝑅𝑃𝑡 𝑛𝑜𝑟𝑚,𝑖 of droplet 𝑖 thus equals: 
 𝑅𝑃𝑡 𝑛𝑜𝑟𝑚,𝑖 =  𝑅𝑃𝑡,𝑖 ⋅ 𝑅𝐼𝑛,𝑖
−1 ⋅ 𝑅𝐼𝑛̅̅ ̅̅̅ ⋅ 𝑚𝑖 ⋅ ?̅?
−1 (1) 
 
𝑤𝑖𝑡ℎ    𝑅𝐼𝑛̅̅ ̅̅̅ =
1
𝑛










The normalized 195Pt responses and absolute Pt masses of each droplet were used to set up the calibration curve. A good linear fit (r² = 
0.9998) to the calibration curve, low absolute limits of detection (90 ag for 195Pt)† and an absolute sensitivity of 45 cts fg-1 were obtained. 
In order to obtain relative concentrations for the radial segment scans, the total ablated tissue mass per pixel (𝑚𝑝) can be calculated based 
on the tissue thickness (𝛿) prior to drying, distance covered during one sweep (𝑥), beam waist dimensions (𝑑) and tissue density (𝜌). 
 𝑚𝑝 = 𝛿 ⋅ 𝑥 ⋅ 𝑑 ⋅ 𝜌 (4) 
The relative sensitivity was calculated at 15 cts/µg g-1 and after error propagation through the whole quantification process, a residual 
standard deviation (RSD) on the relative sensitivity was estimated at 4.2%. 
3. Results and discussion 
3.1. Quantitative imaging of the cisplatin distribution in renal cortex and medulla 
Radial segments of 13.8 mm² (7,079 x 1,950 µm) were selected on sequential H&E-stained and unstained 5 µm thick FFPE kidney tissue 
sections of Cynomolgus monkeys treated with the medium or high dose of cisplatin in order to investigate the cisplatin distribution. For 
the renal medulla, a distinction was made between the outer stripe of the outer medulla (OSOM) and the inner stripe of the outer medulla 
(ISOM). Specific tubular segments located in the OSOM are the thick segments of both the descending (proximal straight tubules) and 
ascending limbs. In the ISOM, thin descending and ascending parts of Henle’s loop and collecting ducts make up the renal tissue. 
Overview scans for an animal treated with the high dose of cisplatin are presented below. Figures 2a and 2c display two brightfield 
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micrographs of the selected radial segments, with an overlay indicating the border between the OSOM and ISOM. Their accompanying 
2D elemental maps in Figures 2b and 2d show the distribution of cisplatin and its metabolites inside the tissue sections on the basis of 
the Pt concentration (expressed in µg g-1) maps. The highest Pt response is observed in the renal cortex, where proximal tubules and 
distal tubules are ubiquitous. This is in accordance with the findings of previous studies [32,35,36,58]. Despite the fact that study animals 
and applied doses of cisplatin differ between all works, the highest accumulation of cisplatin was systematically observed in cortical 
tissue. Vascular elements such as interlobular arteries and veins, marked by the blue arrows in Figures 2a and 2c, can be distinguished 
and show relatively lower responses in the cortical zones. Black arrows point out renal corpuscles, responsible for the blood filtration; 
these glomeruli are characterized by low cisplatin levels as well. When comparing both Pt distribution maps, similar distribution patterns 
are observed for the H&E-stained and unstained tissue sections, as expected. However, in the unstained Pt distribution map, small tubular 
structures, such as some cortical renal corpuscles and lumens of tubular segments in the ISOM, can be distinguished more easi ly. The 
H&E-staining procedure may be able to remobilize the cisplatin to some extent, which is preferably avoided. Hence, all of the following 
experiments were performed on unstained tissue sections. Table 1 contains the average Pt concentrations in the renal cortex and OSOM 
and in the ISOM for an animal treated with the medium and high dose of cisplatin. In both cases, the highest concentrations were observed 
in the region covering the renal cortex and OSOM. Raising the dose of cisplatin from 1.25 to 2.50 µg g-1 bw does not appear to increase 
the local Pt concentration in the ISOM (1.68 ± 0.11 µg g-1 vs. 1.72 ± 0.09 µg g-1), in contrary to the cortex and OSOM, where elevated 
concentrations were observed. Average concentrations in this region increased from 2.47 to 3.29 µg g-1 (33%), likely as a result of the 
increased reabsorption and accumulation of cisplatin in the epithelium of proximal and distal tubules. For rats it is also known that the 
epithelium of proximal straight tubules, present in the OSOM, accumulates high amounts of cisplatin [15]. 
Table 1. Average Pt concentrations in two renal tissue regions (cortex + OSOM and ISOM) of a Cynomolgus monkey treated with a medium and high dose of 
cisplatin based on quantification with Pt-spiked gelatin droplet standards. The results are presented as mean ± standard deviation. For the standard deviation, the 
specific regions were subdivided into five subregions, from which the standard deviation was calculated. Additionally, for the calculation of the standard deviation, 
the uncertainty through the whole data acquisition and reduction process is also taken into account, giving RSDs of 6.5% and 5.2% for the medium and high dose 
tissue sections, respectively. 
Dose of 
cisplatin 
(µg g-1 bw) 
Pt conc. 





1.25 2.47 ± 0.16 1.68 ± 0.11 
2.50 3.29 ± 0.17 1.72 ± 0.09 
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Figure 2. Images of the H&E-stained (a) and unstained (c) kidney tissue sections with the indication of the boundary between the renal OSOM and ISOM 
(curved black line), renal corpuscles (black arrows) and vascular structures (blue arrows). The corresponding quantitative Pt distribution maps of the 
H&E-stained (b) and unstained (d) kidney tissue sections were obtained via LA-ICP-MS with laterally resolved pixels of 15 µm. 
Combining the regions of the OSOM and ISOM enabled the calculation of the average Pt concentrations in medullary tissue, 
corresponding to 1.99 ± 0.13 and 2.10 ± 0.11 µg g-1 for the medium and high dose, respectively. The average medullary Pt concentrations 
are similar for both doses. Egger et al. [32] reported average Pt concentrations of 0.8 and 9 µg g-1 for the renal medulla and cortex in 
mice, sacrificed 24 hours after administration of a 15 µg g-1 bw single dose of cisplatin. Since in our work, the time of sacrifice is 96 
hours after administration and the doses of cisplatin are a factor 6-8 lower, average Pt concentrations in cortical tissue are lower (2.47 - 
3.29 vs. 9 µg g-1). In conclusion, these quantitative results confirm the higher degree of cisplatin reabsorption and accumulation in 
epithelial cells of proximal and distal tubules, in comparison with the tubular segments in the ISOM. 
3.2. High-resolution imaging and combination with histopathological examination of small cortical regions of interest 
Renal tubular lesions were histologically mainly identified in the cortex and OSOM of animals administered with medium and high 
doses of cisplatin - which were very likely induced by the relatively high amount of cisplatin in this zone. Histologically, the proximal 
tubules showed tubular dilatation with swelling and vacuolation of tubular epithelial cells and minimal to mild multifocal necrosis of the 
proximal tubular epithelium with sloughing of these necrotic epithelial cells into the tubular lumen. Additional cisplatin-induced lesions 
were hyaline casts within the lumen of distal tubules and minimal multifocal acute/subchronic cortical inflammation. The glomeruli were 
histologically unaffected at these cisplatin concentrations. 
Specific regions of interest encompassing these microscopic lesions were selected to examine whether or not they could be directly 
linked to regions with high cisplatin concentrations. A composite image of the sequential H&E-stained sections with the ROI zones 
identified was overlaid onto the live image unstained section, based on characteristic marker features that the images share.  Since Pt 
responses for the high-resolution LA-ICP-MS images are very low, Poisson-type noise affected images were denoised applying a high-
quality denoising algorithm in the PureDenoise ImageJ plugin [59]. As can be seen in the high-resolution LA-ICP-MS image in Figure 
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3, the Pt distribution in a region with focal subchronic cortical interstitial inflammation was investigated. The extravascular intertubular 
areas within the renal tissue constitute the interstitium [60]. The subchronic inflammatory cell infiltrate was mainly composed of 
lymphocytes, macrophages and neutrophils [61]. The inflammation extends from the top left corner towards the ROI center. This 
inflammatory region was isolated from the images and after varying the color threshold and applying a mild Gaussian filter, two 8-bit 
type images were combined as a red, green and blue (RGB) color stack in order to visualize the correlation between the presence of 
inflammation and cisplatin. Downsampling of this region was necessary to reduce noise levels. Numerical values were compared pixel-
wise and Spearman’s rank-order correlation coefficient (rs) was calculated in SPSS statistics software. A significant strongly negative 
correlation was determined between the presence of inflammation and cisplatin (r s = -0.958, N = 4015, p < 0.0001) and therefore, the Pt 
response in this inflammation region is very low. Different tubular structures can be recognized in the Pt distribution map and as expected, 
cisplatin is mainly present in the epithelial cells of proximal and distal tubules. Previous studies [35,36] on this topic also indicate the 
accumulation of cisplatin in tubular epithelial cells. The lumens of these tubular segments are low in cisplatin. The luminal diameter of 
distal tubules seems to be larger because of the lack of long microvilli, which are only present in proximal tubules. 
 
Figure 3. High-resolution brightfield micrograph of a selected region with focal subchronic cortical interstitial inflammation on an H&E-stained kidney 
tissue section of an animal treated with the medium dose of cisplatin (bottom left) and the corresponding 195Pt distribution map (bottom right), obtained 
by analyzing the adjacent unstained kidney tissue section with a circular spot size diameter of 3 µm. The 8-bit type images of the isolated inflammation 
region (middle) form the basis of the RGB color stack image which visualizes the negative correlation between the presence of inflammation and cisplatin 
(top). 
In Figure 4, the focus is on the correlation between the accumulation of cisplatin and the presence of focal necrosis of proximal tubular 
epithelial cells. Since epithelial cells of proximal and distal tubules reabsorb significant amounts of cisplatin, accumulation can lead to 
certain cytotoxic levels of cisplatin, which can result into cell death. Necrosis involves drastic irreversible changes in the cytoplasm and 
nucleus [62]. This phenomenon is characterized by the presence of hypereosinophilic round cells with pycnotic nuclei, which are often 
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sloughed into the tubular lumen. These sloughed epithelial cells within the tubular lumen are visible in the high-resolution images of 
Figures 4a - 4c, and correlate strongly to the highest Pt response and therefore, with high accumulation of cisplatin. Especially in Figure 
4b, a large necrotizing tubulus with many sloughed cells in its lumen clearly correlates to the region with the highest Pt response. 
Additionally, black arrows in Figure 4a indicate intratubular hyaline casts, the major constituent of which is the Tamm-Horsfall 
glycoprotein, which is only secreted by the epithelium of the thick ascending limb of Henle’s loop and a short segment of the DCTs [63]. 
In general, these hyaline casts seem to contain low cisplatin concentrations. Furthermore, as seen in Figure 3, the characteristic tubular 
structures can be observed in the Pt distribution maps, thus demonstrating the ability of LA-ICP-MS to reveal cellular cisplatin 
distribution patterns.  
The coupling of the Analyte G2 laser ablation system to the Agilent 7900 ICP-MS allowed even smaller spot sizes down to 1 µm, as a 
direct result of its inherent higher sensitivity. A small ROI (266 x 300 µm) was selected on the H&E-stained tissue section with focal 
tubular necrosis of proximal tubular epithelium and this corresponding area was ablated on the adjacent unstained tissue sect ion. Figure 
4c presents the high-resolution image of this region and the corresponding Pt distribution map. Applying the µm lateral resolution 
increases the measurement time considerably but it provides spatially more detailed information on the cisplatin distribution . The 
boundaries between the different tubular structures can be observed more easily and based on the difference in Pt response within their 
lumens, it is possible to distinguish between proximal and distal tubules. The glomerulus at the right side of the image corresponds to 
the dark blue zone, indicating very low cisplatin accumulation, which is in agreement with the findings of Moreno-Gordaliza et al. [36], 
who indicated cisplatin was absent in glomeruli. In contrast to our results based on a single dose administration, Köppen et al. [35] 
reported the presence of significant amounts of cisplatin in the glomeruli of mice kidneys after cisplatin administration of eight doses of 
4 µg g-1 bw during four weeks (twice a week). In the cortical regions with tubular necrosis, the degree of Pt accumulation is very high in 
comparison with that of the surrounding cortical tissue. The highest cisplatin accumulation in this example can be linked to the presence 
of sloughed necrotic epithelial cells, which appear as round cells with pycnotic nuclei in the lumen of proximal tubules. 
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Figure 4. High-resolution brightfield microscopy images of selected regions of interest with focal necrosis of proximal tubular epithelium on the H&E-
stained kidney tissue sections of Cynomolgus monkeys administered with the medium (a) and high (b and c) dose of cisplatin with the corresponding 
195Pt distribution maps obtained by analyzing the adjacent unstained kidney tissue sections with a circular spot size diameter of 3 (a and b) and 1 µm (c). 
Intratubular hyaline casts are indicated by the black arrows. 
Conclusions 
The mapping of the Pt signal intensities in sections of Cynomolgus monkey kidney tissue via LA-ICP-MS allowed the examination of 
the distribution of the chemotherapeutic drug cisplatin on a cellular scale. Quantitative results were obtained for selected radial segment 
scans based on external calibration with spiked gelatin droplets, giving low absolute limits of detection (90 ag for Pt), good linear fit to 
the calibration curve (r² = 0.9998) and high absolute sensitivity (45 cts fg-1). The combination of the high-resolution Pt distribution maps 
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with minimal to mild microscopic kidney injury identified on adjacent H&E-stained tissue sections demonstrated the correlation between 
microscopic lesions and the local accumulation of cisplatin. The highest accumulation of cisplatin was detected in the renal cortical 
tubules, especially in the tubular epithelial cells. The presence of necrotic proximal tubules with sloughed epithelial cells in their lumen 
correlated strongly to the highest Pt signal responses, which suggests that high accumulation of cisplatin in those areas, directly caused 
multifocal renal damage. The active protective response in regions with subchronic cortical interstitial inflammation showed very low 
cisplatin concentrations in comparison with the surrounding tissue. Very low levels of cisplatin were also demonstrated in hyaline casts, 
but their occurrence could be seen as an indirect pathway of renal damage. This research demonstrated the potential of high-resolution 
bioimaging via LA-ICP-MS by visualizing the cisplatin distribution in Cynomolgus monkey renal tissues on a (sub-)cellular level. 
Notes 
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